— Why it moved
Why SCNI Stock Spiked and Faded Today — October 13, 2026
Scinai Immunotherapeutics dropped news of a manufacturing agreement, prompting an immediate premarket liquidity grab that flunked before the regular session even got started.
What moved SCNI stock
Scinai Immunotherapeutics is a microcap biotech focused on contract development and manufacturing services. They put out a press release announcing a five point one million dollar CDMO deal with a US-based biopharma outfit. Retail chased the headline, but offloading multi-year service contracts into a sub-million-dollar market cap rarely turns into a real re-rating.
The mechanics
With a tiny float of just 488,725 shares and a market cap under eight hundred thousand dollars, any sudden spike in volume was bound to spark violent slippage. Heavy churning drove over 64 million shares in volume as bagholders scrambled to exit.
SCNI by the numbers
The alert window
The alert went out at 7:09 AM with the stock at 2.64. Traders who jumped in got hit with an immediate 12.9 percent drawdown to 2.30 before a brief push to the 3.0 peak at 7:17 AM. That eight-minute window gave a minor 13.6 percent pop, but the stock spent just seven minutes above the alert price for the entire day.
How SCNI's move ended
The stock spent the rest of the day in freefall, closing at 1.24 for a brutal 53.2 percent drop from the alert level. With a 52-week low hovering near 1.06, this was a classic low-float trap where the early pop existed purely to dump shares on late chasers.
The tell: When a tiny float pops on multi-year contract news in premarket trading, the entire move is usually over before regular session trading begins.